{"brief_title": "Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection", "brief_summary": "This study was designed to provide early access to and evaluate the safety of TPV/r in PI-experienced patients with HIV-1 infection.", "condition": ["HIV Infections"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Tipranavir", "Ritonavir"], "description": ["500 mg twice daily", "200 mg twice daily"], "mesh_term": ["Infection", "Communicable Diseases", "HIV Infections", "Ritonavir", "Tipranavir"], "id": "NCT00097799"}